-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
January 01, 2011 - Number of Beneficiaries, Number of Claims, and
Total Medicare Reimbursement in File Type by
5-Digit … ,
2006-2009
Number of Beneficiaries, Number of Claims, and
Total Medicare Reimbursement in File Type … ,
2006-2009
Number of Beneficiaries, Number of Claims, and
Total Medicare Reimbursement in File Type … ,
2006-2009
Number of Beneficiaries, Number of Claims, and
Total Medicare Reimbursement in File Type … ,
2006-2009
Number of Beneficiaries, Number of Claims, and
Total Medicare Reimbursement in File Type
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-radiation_executive.pdf
November 01, 2009 - The spectrum of included patients varied depending on
the cancer type. … Comparators assessed in the randomized controlled trials
Cancer type and center Comparison N Survival … Comparators assessed in the nonrandomized comparative studies
Cancer type and center Comparison N Survival
-
effectivehealthcare.ahrq.gov/sites/default/files/presentation.ppt
August 01, 2009 - One can readily appreciate the number of studies conducted — stratified by cancer type, designs, and … This type of summary could tempt readers to draw a mental summary effect, so its purpose should be stated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
January 01, 2009 - If the benefits of an existing test-plus-treatment strategy
have already been established, the type … identify what types of comparative evidence are needed to evaluate a
new test; (2) describe how the type … • Specify the type of comparative evidence needed to measure these
differences. … Multiple flow diagrams may
be needed if the role of the new test or the type of comparator differs for … Identifying the Type of Comparative Evidence Needed
for Test Evaluation
1.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
January 01, 2021 - Caucasian: 41% vs. 33% vs. 37%
Duration of symptoms: 42 vs. 47 vs. 67 months, p<0.001
Pain etiology/type … 43 vs. 37 vs. 37 years
Female: 77% vs. 78% vs. 75%
Race: NR
Duration of symptoms: NR
Pain etiology/type … B
Age: 66 vs. 66 years
Female: NR
Race: NR
Duration of symptoms: NR
Pain etiology/type or diagnostic … (years):
≤1: 3% vs. 5%
< 1 to 5: 50% vs. 32%
< 5 to 10: 29% vs. 44%
> 10: 19% vs. 20%
Pain etiology/type … C
Age: NR
Female: NR
Race: NR
Ethnicity: NR
Duration of Symptoms: NR
Pain etiology/type or diagnostic
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
January 01, 2021 - Caucasian: 41% vs. 33% vs. 37%
Duration of symptoms: 42 vs. 47 vs. 67 months, p<0.001
Pain etiology/type … 43 vs. 37 vs. 37 years
Female: 77% vs. 78% vs. 75%
Race: NR
Duration of symptoms: NR
Pain etiology/type … B
Age: 66 vs. 66 years
Female: NR
Race: NR
Duration of symptoms: NR
Pain etiology/type or diagnostic … (years):
≤1: 3% vs. 5%
< 1 to 5: 50% vs. 32%
< 5 to 10: 29% vs. 44%
> 10: 19% vs. 20%
Pain etiology/type … C
Age: NR
Female: NR
Race: NR
Ethnicity: NR
Duration of Symptoms: NR
Pain etiology/type or diagnostic
-
effectivehealthcare.ahrq.gov/sites/default/files/community-based-participatory-research-slides.pptx
January 01, 2013 - Please use the chat feature to type and submit your questions. … community benefit program since 2009
Comprehensive diabetes management for adult, medically underserved, Type … and patient input, we added a food security measure and learned that almost 57% of the patients with type … Community Forum
Community Forum
Please remember to use the chat feature to type and submit your questions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/quality-gap-palliative-hospice_research-protocol.pdf
June 27, 2011 - Comparators
For KQ 1, we will abstract the type(s) of QI interventions used in each article … evaluate applicability for included studies,
we will extract the relevant patient population (cancer type
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - Type of control group (historic control vs. concurrent control vs. none)
4. … Design Brief
Description
Control Control Type Followup Temporality Strengths Weaknesses Readings … Design Brief
Description
Control Control Type Followup Temporality Strengths Weaknesses Readings … Design Brief
Description
Control Control Type Followup Temporality Strengths Weaknesses Readings … We are not aware of published hedges for this type of exclusion.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - Type of control group (historic control vs. concurrent control vs. none)
4. … Design Brief
Description
Control Control Type Followup Temporality Strengths Weaknesses Readings … Design Brief
Description
Control Control Type Followup Temporality Strengths Weaknesses Readings … Design Brief
Description
Control Control Type Followup Temporality Strengths Weaknesses Readings … We are not aware of published hedges for this type of exclusion.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - denote subcategories within a broad priority
area (e.g., breast cancer, peripheral artery disease, type … Meeting abstracts reviewed for leads (continued)
A-14
Resource Name and Type (1-11;
see Key at … Meeting abstracts reviewed for leads (continued)
A-15
Resource Name and Type (1-11;
see Key at … Meeting abstracts reviewed for leads (continued)
A-16
Resource Name and Type (1-11;
see Key at … 1, Type 2, Metabolic Syndrome
08 Functional limitations and disability
Examples of subcategories:
-
effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
September 01, 2015 - denote subcategories within a broad priority
area (e.g., breast cancer, peripheral artery disease, type … Meeting abstracts reviewed for leads (continued)
A-14
Resource Name and Type (1-11;
see Key at … Meeting abstracts reviewed for leads (continued)
A-15
Resource Name and Type (1-11;
see Key at … Meeting abstracts reviewed for leads (continued)
A-16
Resource Name and Type (1-11;
see Key at … 1, Type 2, Metabolic Syndrome
08 Functional limitations and disability
Examples of subcategories:
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/field-triage-glascow_executive.pdf
January 01, 2017 - These include variability
in patient populations (e.g., type of trauma, demographic
characteristics … the tGCS or mGCS, timing, or setting) impacted results,
as well as study design characteristics (type … were similar in
subgroups stratified by age (child vs. mixed populations
of adults and children), type … • Type of trauma: Effects on discrimination between the
tGCS versus the mGCS were similar in studies … applicability of the
evidence, its applicability to specific patient populations
(e.g., specific type
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_clinician.pdf
August 01, 2015 - potential benefits and the acute and late harms of the
proposed RT for the individual patient given the type … patient’s and/or caregiver’s preferences
�� The likely out-of-pocket expense to the patient for each
type
-
effectivehealthcare.ahrq.gov/sites/default/files/dyspnea-advanced-cancer-summary-1.pdf
November 01, 2020 - Interventions for Breathlessness in Patients With Advanced Cancer: Evidence Summary
Comparative Effectiveness Review
Number 232
Interventions for Breathlessness in
Patients With Advanced Cancer
Evidence Summary
Main Points
For patients with advanced cancer:
• Airflow interventions (fans) were …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-agitation-aggression_research-protocol.pdf
November 13, 2014 - delivered directly to patients with dementia to reduce agitated and aggressive behavior
Intervention
Type … Source: www.effectivehealthcare.ahrq.gov
Published online: November 13, 2014
5
Intervention
Type … Criteria for Inclusion
Study Enrollment Studies that enroll persons diagnosed with dementia (any type … Publication type Published in peer reviewed journals.
Language of
Publication
English
B. … Agitated behavior in persons with dementia: the relationship between type of
behavior, its frequency
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - 1 receptor blockers"[MeSH Terms] OR "angiotensin ii type 1 receptor blockers"[tw] OR
"angiotensin … Aliskiren combined with losartan in type 2 diabetes and
nephropathy. … Renal effects of aliskiren compared with and in
combination with irbesartan in patients with type 2 … Aliskiren combined with losartan in type 2 diabetes and
nephropathy. … Aliskiren combined with losartan in type 2 diabetes and
nephropathy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-making-sure-evidence-understood.pdf
July 01, 2020 - Making Sure That Evidence Is Understood and Used
Making Sure That Evidence
Is Understood and Used:
Engaging With the Agency
for Healthcare Research and
Quality in Evidence Reviews
Why Engage With AHRQ?
The Agency for Healthcare Research and Quality (AHRQ) wants to engage with
organizations to promote the use…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_technical-brief.pdf
December 01, 2014 - Distribution of All Abstracts by Study Type ......................................................... … Distribution of All Abstracts by Skin Cancer Type ................................................... … Type of techniques/modalities
b. Postulated advantages and
disadvantages? … Distribution of all abstracts by study type
RCT = randomized, controlled trial
Over half of the … This type can be in either reflectance or
fluorescence mode.
-
effectivehealthcare.ahrq.gov/sites/default/files/shah.pdf
May 29, 2025 - We
might refer to that as a Web 1.0-type portal where there's a lot of great
content. … terminology that we use today, but then it moved
into what I would -- I would call the second generation-type … You know, I think physicians are -- are used to
being hammered by, you know, all kinds of marketing-type … Where all the others are sort of voluntary-type communities where people come in
and you really have